SCHEMBL7879482

SCHEMBL7879482

COC(=O)c1cc2cccc(O)c2n1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.50
CA12 O43570 2/20 0.49
CA1 P00915 2/20 0.49
CA2 P00918 2/20 0.49
CA7 P43166 2/20 0.49
CA9 Q16790 2/20 0.49
CA14 Q9ULX7 2/20 0.49
KDM4E B2RXH2 2/20 0.45
MAPT P10636 3/20 0.43
LMNA P02545 2/20 0.42
TSHR P16473 1/20 0.42
MTNR1A P48039 1/20 0.41
MTNR1B P49286 1/20 0.41
TP53 P04637 1/20 0.39
BRD4 O60885 1/20 0.39
KDM4A O75164 1/20 0.39
MCL1 Q07820 1/20 0.38
CTSV O60911 1/20 0.38
XDH P47989 1/20 0.38
CLK1 P49759 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7880056 0.84 L3MBTL1 (0.50) L3MBTL1KDM4EMAPTLMNATSHR
SCHEMBL3160370 0.84 CA12 (0.53) CA12CA1CA2CA7CA9
SCHEMBL7881808 0.83 L3MBTL1 (0.49) L3MBTL1KDM4EMAPTLMNATSHR
SCHEMBL3229944 0.82 MCL1 (0.57) KDM4ETSHRMCL1CLK1DYRK1A
SCHEMBL27480342 0.77 L3MBTL1 (0.44) L3MBTL1KDM4EMAPTLMNATSHR
SCHEMBL29834903 0.76 L3MBTL1 (0.67) L3MBTL1KDM4EMAPTLMNAMTNR1A
SCHEMBL4486403 0.76 L3MBTL1 (0.67) L3MBTL1KDM4EMAPTLMNAMTNR1A
SCHEMBL7877791 0.76 L3MBTL1 (0.42) L3MBTL1KDM4EMAPTLMNAMTNR1A
SCHEMBL7877726 0.75 MAPT (0.45) L3MBTL1KDM4EMAPTLMNATSHR
SCHEMBL7880731 0.74 SRD5A2 (0.52) L3MBTL1MAPTLMNABRD4HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1067988-C Indoloylguanidine derivatives SUMITOMO PHARMACEUTICS K K (JP) 2001-07-04 CN disclosed
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
CN-1051301-C Indoloylguanidine derivatives SUMITOMO PHARMA (JP) 2000-04-12 CN disclosed
EP-0622356-B1 Indoloylguanidine derivatives as inhibitors of sodium-hydrogen exchange SUMITOMO PHARMA (JP) 1998-07-01 EP disclosed
CN-1136038-A Indoloylguanidine derivatives SUMITOMO PHARMACEUTICS K K (JP) 1996-11-20 CN disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed
CN-1106800-A Indoloylguanidine derivatives SUMITOMO PHARMA (JP) 1995-08-16 CN disclosed
EP-0622356-A1 Indoloylguanidine derivatives as inhibitors of sodium-hydrogen exchange SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1994-11-02 EP disclosed